Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the
WHO-EORTC classification for cutaneous lymphomas. Blood
2019;133(16):1703–1714....
Mehta-Shah N, Horwitz SM, Ansell S, et al. NCCN Guidelines
Insights: primary cutaneous lymphomas, version 2.2020. J Natl
Compr Cancer Netw....
Pujol RM, Gallardo F. Linfomas cutáneos. Parte I: micosis
fungoide, síndrome de Sézary y proliferaciones linfoides
cutáneas CD30 positivas....
Albedaño A, Argerich C, Acosta AC, et al. Consenso linfomas
cutáneos primarios, actualización 2019. Sociedad Argentina de
Dermatología; 2019...
Kempf W, Pfaltz K, Vermeer MH, et al. EORTC, ISCL, and USCLC
consensus recommendations for the treatment of primary
cutaneous CD30-positive...
Prince HM, Kim YH, Horwitz SM, et al. Brentuximab vedotin or
physician’s choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international,...
Horwitz S, O’Connor OA, Pro B, et al. Brentuximab vedotin with
chemotherapy for CD30-positive peripheral T-cell lymphoma
(ECHELON-2): a global,...
Melchers RC, Willemze R, Bekkenk MW, et al. Frequency and
prognosis of associated malignancies in 504 patients with
lymphomatoid papulosis....
Zargaran D, Zoller FE, Zargaran A, et al. Complications of facial
cosmetic botulinum toxin A injection: analysis of the UK
Medicines &...